» Articles » PMID: 37287573

The Joint Impacts of Sex and Race/ethnicity on Incidence of Grade 1 Versus Grades 2-3 Meningioma Across the Lifespan

Overview
Journal Neurooncol Adv
Date 2023 Jun 8
PMID 37287573
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous research has identified older age, African-American race, and female sex as meningioma risk factors, but there is limited information on their joint effects, or on how these demographic factors vary across strata of tumor grade.

Methods: The Central Brain Tumor Registry of the United States (CBTRUS) is a population-based registry combining data from the CDC's National Program of Cancer Registries and NCI's Surveillance, Epidemiology and End Results Program which covers ~100% of the U.S. population and aggregates incidence data on all primary malignant and nonmalignant brain tumors. These data were used to explore the joint impacts of sex and race/ethnicity on average annual age-adjusted incidence rates of meningioma. We calculated meningioma incidence rate ratios (IRRs) by sex and race/ethnicity, across strata of age and tumor grade.

Results: Compared to individuals who are non-Hispanic White, individuals who are non-Hispanic Black had significantly higher risk of grade 1 (IRR = 1.23; 95% CI: 1.21-1.24) and grade 2-3 meningioma (IRR = 1.42; 95% CI: 1.37-1.47). The female-to-male IRR peaked in the fifth decade of life across all racial/ethnic groups and tumor grades, but was 3.59 (95% CI: 3.51-3.67) for WHO grade 1 meningioma and 1.74 (95% CI: 1.63-1.87) for WHO grade 2-3 meningioma.

Conclusions: This study reveals the joint effects of sex and race/ethnicity on meningioma incidence throughout the lifespan and across strata of tumor grade, highlighting incidence disparities among females and African-Americans that may inform future strategies for tumor interception.

Citing Articles

Malignant Meningiomas: From Diagnostics to Treatment.

Rowbottom H, Smigoc T, Ravnik J Diagnostics (Basel). 2025; 15(5).

PMID: 40075786 PMC: 11898517. DOI: 10.3390/diagnostics15050538.


Grade-stratified meningioma risk among individuals who are non-Hispanic Black and interactions with male sex.

Walsh K, Price M, Raleigh D, Calabrese E, Kruchko C, Barnholtz-Sloan J J Natl Cancer Inst. 2024; 117(2):366-374.

PMID: 39392420 PMC: 11807431. DOI: 10.1093/jnci/djae253.


CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.

Price M, Neff C, Nagarajan N, Kruchko C, Waite K, Cioffi G Neuro Oncol. 2024; 26(Supplement_3):iii1-iii53.

PMID: 38709657 PMC: 11073545. DOI: 10.1093/neuonc/noae047.


Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.

Wang J, Landry A, Raleigh D, Sahm F, Walsh K, Goldbrunner R Neuro Oncol. 2024; 26(10):1742-1780.

PMID: 38695575 PMC: 11449035. DOI: 10.1093/neuonc/noae082.


Association of county-level socioeconomic status with meningioma incidence and outcomes.

Pugazenthi S, Price M, De La Vega Gomar R, Kruchko C, Waite K, Barnholtz-Sloan J Neuro Oncol. 2023; 26(4):749-763.

PMID: 38087980 PMC: 10995507. DOI: 10.1093/neuonc/noad223.

References
1.
Hage M, Plesa O, Lemaire I, Raffin Sanson M . Estrogen and Progesterone Therapy and Meningiomas. Endocrinology. 2021; 163(2). DOI: 10.1210/endocr/bqab259. View

2.
Claus E, Cornish A, Broderick P, Schildkraut J, Dobbins S, Holroyd A . Genome-wide association analysis identifies a meningioma risk locus at 11p15.5. Neuro Oncol. 2018; 20(11):1485-1493. PMC: 6176799. DOI: 10.1093/neuonc/noy077. View

3.
Lin D, Lin J, Deng X, Li W, Li D, Yin B . Trends in intracranial meningioma incidence in the United States, 2004-2015. Cancer Med. 2019; 8(14):6458-6467. PMC: 6797634. DOI: 10.1002/cam4.2516. View

4.
Pravdenkova S, Al-Mefty O, Sawyer J, Husain M . Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg. 2007; 105(2):163-73. DOI: 10.3171/jns.2006.105.2.163. View

5.
Ostrom Q, Egan K, Nabors L, Gerke T, Thompson R, Olson J . Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics. Int J Cancer. 2019; 146(3):739-748. PMC: 6785354. DOI: 10.1002/ijc.32318. View